| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $13.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 15,000 | $55.10 | $826,564.50 | -7.6% | -23.3% | -6.5% | |
| Nov 11, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 30,000 | $55.62 | $1,668,678.36 | -7.0% | -28.2% | +0.6% | |
| Oct 14, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 4,293 | $46.28 | $198,680.04 | -1.9% | -18.8% | +45.1% | |
| Apr 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 19,582 | $59.91 | $1,173,231.52 | -4.5% | -2.1% | -33.7% | |
| Mar 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $72.48 | $1,449,628.16 | -4.5% | -10.5% | -42.3% | |
| Mar 12, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 14,385 | $77.04 | $1,108,263.04 | -3.4% | -20.3% | -42.2% | |
| Feb 20, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 6,370 | $79.67 | $507,497.90 | -3.2% | -29.5% | -32.7% | |
| Feb 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $80.36 | $1,607,177.46 | -3.4% | -32.6% | -41.1% | |
| Jan 29, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,000 | $60.51 | $3,025,572.69 | -11.8% | -16.6% | -36.4% | |
| Jan 16, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $62.50 | $1,250,058.00 | -9.6% | -7.4% | -38.5% |